Literature DB >> 1280875

Development of a control strategy for Leptospira hardjo infection in a closed beef herd.

T W Little1, S C Hathaway, E S Boughton, D Seawright.   

Abstract

Serological evidence of infection with a leptospire belonging to the Sejroe serogroup was identified in a closed population of Luing cattle in the west of Scotland, and the geographical isolation of the population presented an opportunity to control and possibly eradicate the infection in a large beef herd farmed under extensive conditions. Serological and bacteriological studies revealed that infection was present at a high level throughout the herd, and that the infecting serovar was hardjo. Unlike endemic hardjo infection in dairy herds, new infections were still occurring in older age-groups. Investigations of other domestic and free-living species sharing the habitat demonstrated that the maintenance of an endemic focus of hardjo was restricted to the cattle. Changes in management to prevent the transmission of infection to successive cohorts of young animals were impractical and risky, and antibiotic treatment followed by removal to clean pasture failed to prevent new cases. Thus vaccination offered the only means of control and possible eradication, and the epidemiological characteristics of the infection dictated that the programme be applied to the whole herd.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1280875     DOI: 10.1136/vr.131.17.383

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  2 in total

1.  Leptospirosis vaccines.

Authors:  Zhijun Wang; Li Jin; Alicja Wegrzyn
Journal:  Microb Cell Fact       Date:  2007-12-11       Impact factor: 5.328

2.  Application of an integrated outbreak management plan for the control of leptospirosis in dairy cattle herds.

Authors:  L Mughini-Gras; L Bonfanti; A Natale; A Comin; A Ferronato; E La Greca; T Patregnani; L Lucchese; S Marangon
Journal:  Epidemiol Infect       Date:  2013-08-07       Impact factor: 4.434

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.